Overview
Query ClinicalTrials.gov (NIH/NLM API v2) for one study by NCT ID or search by condition, drug/intervention, sponsor, status, and phase. Use before biotech catalyst checks, drug pipeline research, or trial eligibility screening. Returns normalized JSON with status, phase, sponsor, enrollment, dates, primary outcomes, countries, and source timestamps. Registry facts only; not medical advice.
Protocol
x402
Price
$0.0050
Payment Asset
USD Coin
Payment Network
eip155:8453
Category
tools/search
Provider
Clinical Trial Fact Pack
Indexed
2026-11-22 16:11:36
Health
Status
unknown
Latency (p50)
—
Uptime (30d)
—
Reliability Score
—
Last Checked
Never
Last Healthy
Never
Consecutive Failures
0
Input Schema
{
"method": "GET",
"queryParams": {
"condition": "asthma",
"limit": "2",
"phase": "PHASE3",
"status": "RECRUITING"
},
"type": "http"
}
Output Schema
{
"example": {
"disclaimer": "Informational registry data only; not medical advice and not endorsed by NLM, NIH, or HHS.",
"license": "ClinicalTrials.gov Terms and Conditions (https://clinicaltrials.gov/about-site/terms-conditions)",
"mode": "search",
"modifications": "Selected structured protocol fields normalized into compact JSON; site contact names, emails, and phone numbers omitted; eligibility criteria truncated to 500 characters.",
"query": {
"condition": "asthma",
"intervention": null,
"limit": 2,
"nctId": null,
"phase": "PHASE3",
"q": null,
"sponsor": null,
"status": [
"RECRUITING"
]
},
"returned": 1,
"source": "ClinicalTrials.gov (U.S. National Library of Medicine, API v2)",
"sourceUrl": "https://clinicaltrials.gov/api/v2/studies?query.cond=asthma&filter.overallStatus=RECRUITING&filter.advanced=AREA%5BPhase%5DPHASE3&pageSize=2&countTotal=true",
"studies": [
{
"briefTitle": "Example Phase 3 Study in Moderate-to-Severe Asthma",
"conditions": [
"Asthma"
],
"countries": [
"Canada",
"United States"
],
"dates": {
"completionDate": "2027-12-31",
"lastUpdatePostDate": "2026-11-15",
"primaryCompletionDate": "2027-06-30",
"startDate": "2026-03-01"
},
"eligibility": {
"criteriaExcerpt": "Inclusion Criteria: Confirmed physician diagnosis of persistent asthma for at least 12 months.",
"healthyVolunteers": false,
"maximumAge": "75 Years",
"minimumAge": "18 Years",
"sex": "ALL"
},
"enrollment": {
"count": 420,
"type": "ESTIMATED"
},
"hasResults": false,
"interventions": [
{
"name": "Example Biologic 300mg",
"type": "BIOLOGICAL"
}
],
"nctId": "NCT00000001",
"officialTitle": "A Randomized, Double-Blind Phase 3 Study of Example Therapy in Adults With Asthma",
"overallStatus": "RECRUITING",
"phases": [
"PHASE3"
],
"primaryOutcomes": [
{
"measure": "Annualized rate of severe asthma exacerbations",
"timeFrame": "52 weeks"
}
],
"siteCount": 24,
"sponsor": {
"class": "INDUSTRY",
"name": "Example Therapeutics"
},
"studyType": "INTERVENTIONAL",
"studyUrl": "https://clinicaltrials.gov/study/NCT00000001",
"whyStopped": null
}
],
"summary": {
"byPhase": {
"PHASE3": 1
},
"byStatus": {
"RECRUITING": 1
},
"withResults": 0
},
"timestamp": "2026-11-22T12:00:00.000Z",
"totalMatched": 1
},
"type": "json"
}